Resources

Websitewww.bioclones.co.za

Founders

1 MEMBERS

Ismet Amod

CEO

News & Activity

News and activity

Recent coverage, notable milestones, and hiring momentum that add context around Genius Biotherapeutics.

Funding Health

Total raised—

Rounds—

Last round—

Time since last funding—

Investors

—

Traction Signals

Web rank—

App rating (best)—

Reviews tracked—

Twitter followers

—

Domain & Risk

Domain statusunknown

Domain age—

Expires—

Signals are computed from available datasets. Missing values indicate no data is currently tracked.

Market Intelligence

Live

NEWS

10 months ago

Sonnet BioTherapeutics Stock Plunges 15.66% Amid Capital Raise

https://www.ainvest.com/news/sonnet-biotherapeutics-stock-plunges-15-66-capital-raise-2507/

NEWS

11 months ago

From Teenage Sweethearts to Pioneers in Cancer Therapy: The Story Behind Creative BioTherapeutics

https://www.usatoday.com/story/special/contributor-content/2025/06/06/from-teenage-sweethearts-to-pioneers-in-cancer-therapy-the-story-behind-creative-biotherapeutics/84069748007/

Universiteit Leiden

1 year ago

Prof. Johan Kuiper will retire as of November 1st 2024 after 40 years of research and education

https://www.universiteitleiden.nl/en/news/2024/10/prof.-johan-kuiper-will-retire-as-of-november-1st-2024-after-40-years-of-research-and-education

Sick Economics

1 year ago

3 Hot New Biotech Launches For Your Sweltering Summer

https://www.sickeconomics.com/2024/06/05/three-hot-new-biotech-launches-summer-2024/

NEWS

2 years ago

LabGenius cements £35M to advance AI-powered antibody discovery platform

https://techfundingnews.com/labgenius-cements-35m-to-advance-ai-powered-antibody-discovery-platform/

Labiotech.eu

3 years ago

LabGenius to create molecules with increase in tumor killing ability

https://www.labiotech.eu/trends-news/labgenius-molecules-increased-tumor-killing-ability/

Sign in to view more

Join the largest community of African tech investors and founders.

Create Free Account

Already have an account? Log in

Resources

Websitewww.bioclones.co.za

Founders

Key Insights

Live

Ecosystem Rank

Ranked

—

App Rating

N/A

No reviews data

—

Twitter Followers

Audience size

—

Comparable Peers

AzarGen Biotechnologies

Stellenbosch, South Africa

Immobazyme

Stellenbosch, South Africa

Latest Intelligence

10 months agoNEWS

Sonnet BioTherapeutics Stock Plunges 15.66% Amid Capital Raise

11 months agoNEWS

From Teenage Sweethearts to Pioneers in Cancer Therapy: The Story Behind Creative BioTherapeutics

1 year agoUniversiteit Leiden

Genius Biotherapeutics

Resources

Founders

Backed By

Similar Companies

Sector & Tech

News and activity

Sign in to view more

Resources

Founders

Key Insights

Comparable Peers

Latest Intelligence

Sonnet BioTherapeutics Stock Plunges 15.66% Amid Capital Raise

From Teenage Sweethearts to Pioneers in Cancer Therapy: The Story Behind Creative BioTherapeutics

Prof. Johan Kuiper will retire as of November 1st 2024 after 40 years of research and education

Backed By

Similar Companies

Sector & Tech